LBA2 ALINA: Efficacy and Safety of Adjuvant Alectinib Versus Chemotherapy in Patients with Early-Stage ALK+ Non-Small Cell Lung Cancer (NSCLC)

Annals of Oncology(2023)

引用 0|浏览33
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要